Changes in the Consumption of Psychoactive Substances During Containment Linked to COVID-19

Changes in the Consumption of Psychoactive Substances by People Incarcerated at the Villeneuve-Lès-Maguelone Prison During Containment Linked to COVID-19.

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04380714

Enrollment

700

Registered

2020-05-08

Start date

2020-05-01

Completion date

2020-08-01

Last updated

2020-12-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

COVID-19, People Incarcerated

Brief summary

The SARS-CoV 2 pandemic started in China in December 2019, then reached France on January 24, 2020. On March 14, France moved into phase 3 of the epidemic threshold with the implementation of containment measures on March 17 Measures were put in place by N.Belloubet (French Minister of Justice) from March 17, including suspension of visiting rooms and activities in detention. Containment provides boredom and isolation with many potential consequences: sleep disturbance, anxiety, PTSD, depression, suicide, addictive behavior and violence. However,prisoners have a higher prevalence of substance use disorders than the general population. What will have been the impact of the confinement on the consumption of psychoactive substances by prisoners at the Villeneuve Les Maguelone prison. * Anonymous questionnaire from the start * Collection of socio-demographic data * Collection of consumption data before and during containment * Collection of monitoring data

Interventions

None listed

Study design

Observational model

ECOLOGIC_OR_COMMUNITY

Time perspective

CROSS_SECTIONAL

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Yes

Inclusion criteria

* Men incarcerated at Villeneuve Les Maguelone prison * On a given date (May 12) * Major * French speaking * non illiterate

Exclusion criteria

* minors * patients refusing * non-French speaking * illiterate

Design outcomes

Primary

Measure	Time frame	Description
percentage changes in the consumption of psychoactive substances	1 day	percentage changes in the consumption of psychoactive substances

Secondary

Measure	Time frame	Description
Assessment of the level of stress	1 day	Assessment of the level of stress by self-administered questionnaire before / during confinement
Assessment of depression	1 day	Assessment of depression by self-administered questionnaire before / during confinement
Craving modification evaluation	1 day	Craving modification evaluation

Countries

France

Outcome results